Update on the role of circulating tumour cells in cancer-associated thrombosis

by John Castle, Emma Blower, Cliona C. Kirwan
Published 2021-12-01

Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.

by John Castle, Karen Morris, Susan Pritchard, Cliona C Kirwan
Published 2017-01-01

Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study...

by John Castle, Emma Blower, Nigel J. Bundred, James R. Harvey, Jecko Thachil, Andrea Marshall, Karina Cox, Silvia Cicconi, Chris Holcombe, Carlos Palmieri, Cliona C. Kirwan
Published 2020-08-01

Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre‐invasive phenomena that is prognostic in invasion

by Hudhaifah Shaker, Nigel J. Bundred, Göran Landberg, Susan A. Pritchard, Harith Albadry, Sarah L. Nicholson, Lauren J. Harries, Jing Y. E. Heah, John Castle, Cliona C. Kirwan
Published 2020-03-01

Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells

by Friedrich Foerster, Sebastian Boegel, Rosario Heck, Geetha Pickert, Nina Rüssel, Sebastian Rosigkeit, Matthias Bros, Stephanie Strobl, Leonard Kaps, Misbah Aslam, Mustafa Diken, John Castle, Ugur Sahin, Andrea Tuettenberg, Ernesto Bockamp, Detlef Schuppan
Published 2018-04-01

Abstract: Results of the XPAND II Multi-Center, Prospective Clinical Trial for the AeroForm Tissue Expander System used for Two-Stage Breast Reconstruction

by Jeffrey A. Ascherman, MD, Kamakshi R. Zeidler, MD, Kerry A. Morrison, MD, James Appel, MD, Khashayar Mohebali, MD, Tracey H. Stokes, MD, Laura A. Sudarsky, MD, CWSP, FACS, Yoon S. Chun, MD, Amy Colwell, MD, John Castle, MD
Published 2017-09-01